ATE191278T1 - Tetrahydroxychinon als eine aktivatorkomponente für den aktivierten partiellen thromboplastinzeit-test der blutgerinnung und als anzeiger von blutgerinnungsstörungen - Google Patents

Tetrahydroxychinon als eine aktivatorkomponente für den aktivierten partiellen thromboplastinzeit-test der blutgerinnung und als anzeiger von blutgerinnungsstörungen

Info

Publication number: ATE191278T1
Authority: AT; Austria
Prior art keywords: blood clotting; tetrahydroxyquinone; indicator; time test; partial thromboplastin
Prior art date: 1993-11-04

Application number

AT95901136T

Other languages

English (en)

Inventor

Ted C K Lee

Franz Hermann Pelzer

Leslie A Motley

Original Assignee

Dade Behring Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-11-04

Filing date

1994-11-04

Publication date

2000-04-15

1994-11-04 Application filed by Dade Behring Inc filed Critical Dade Behring Inc

2000-04-15 Application granted granted Critical

2000-04-15 Publication of ATE191278T1 publication Critical patent/ATE191278T1/de

Links

230000023555 blood coagulation Effects 0.000 title abstract 4
PGOHTUIFYSHAQG-LJSDBVFPSA-N (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O PGOHTUIFYSHAQG-LJSDBVFPSA-N 0.000 title abstract 2
102000002262 Thromboplastin Human genes 0.000 title abstract 2
108010000499 Thromboplastin Proteins 0.000 title abstract 2
239000012190 activator Substances 0.000 title abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
DGQOCLATAPFASR-UHFFFAOYSA-N tetrahydroxy-1,4-benzoquinone Chemical compound OC1=C(O)C(=O)C(O)=C(O)C1=O DGQOCLATAPFASR-UHFFFAOYSA-N 0.000 title 1
239000003153 chemical reaction reagent Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
- Y10T436/106664—Blood serum or blood plasma standard or control

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Hematology (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Food Science & Technology (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Microbiology (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Investigating Or Analysing Biological Materials (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT95901136T 1993-11-04 1994-11-04 Tetrahydroxychinon als eine aktivatorkomponente für den aktivierten partiellen thromboplastinzeit-test der blutgerinnung und als anzeiger von blutgerinnungsstörungen ATE191278T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US14813993A	1993-11-04	1993-11-04
PCT/US1994/012693 WO1995012818A1 (en)	1993-11-04	1994-11-04	Tetrahydroxyquinone as an activator component for activated partial thromboplastine time test of blood coagulation and as a detector of blood coagulation disorders

Publications (1)

Publication Number	Publication Date
ATE191278T1 true ATE191278T1 (de)	2000-04-15

Family

ID=22524463

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95901136T ATE191278T1 (de)	1993-11-04	1994-11-04	Tetrahydroxychinon als eine aktivatorkomponente für den aktivierten partiellen thromboplastinzeit-test der blutgerinnung und als anzeiger von blutgerinnungsstörungen

Country Status (8)

Country	Link
US (1)	US5550028A (de)
EP (1)	EP0677171B1 (de)
JP (1)	JPH08510057A (de)
AT (1)	ATE191278T1 (de)
AU (1)	AU674265B2 (de)
CA (1)	CA2152954A1 (de)
DE (1)	DE69423738T2 (de)
WO (1)	WO1995012818A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT405692B (de) *	1997-03-27	1999-10-25	Immuno Ag	Reagens zur bestimmung der aptt
ATE268477T1 (de)	1999-09-03	2004-06-15	Roche Diagnostics Corp	Verfahren, reagenz und messkartusche zur bestimmung der gerinnungszeit
US6448024B1 (en)	2000-10-03	2002-09-10	Roche Diagnostics Corporation	Method, reagent, cartridge, and device for determining fibrinogen
JP6577778B2 (ja) *	2015-07-30	2019-09-18	シスメックス株式会社	凝固時間の測定方法およびその装置、凝固時間測定用試薬ならびに試薬キット
CN112740034B (zh) *	2018-09-25	2024-09-17	积水医疗株式会社	测定凝血时间的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3486981A (en) *	1965-03-15	1969-12-30	Roy E Speck	Substances relating to testing of blood-coagulation
BE722746A (de) *	1967-11-09	1969-04-01
US3839317A (en) *	1973-06-29	1974-10-01	Interx Research Corp	Digoxin complexes
US3880714A (en) *	1973-07-18	1975-04-29	Warner Lambert Co	Diagnostic reagent
JPS60174952A (ja) *	1984-02-21	1985-09-09	Sekisui Chem Co Ltd	血液凝固促進剤
DE3407280A1 (de) *	1984-02-28	1985-09-19	Gödecke AG, 1000 Berlin	Testsatz zur bestimmung der aktivierten partiellen thromboplastinzeit (ptt) mit erhoehter heparinempfindlichkeit
CA1313997C (en) *	1986-04-11	1993-03-02	Hideo Anraku	Accelerator of the activity of hydrolase
US5126247A (en) *	1988-02-26	1992-06-30	Enzymatics, Inc.	Method, system and devices for the assay and detection of biochemical molecules
US5055412A (en) *	1989-03-21	1991-10-08	Proksch Gary J	Factor sensitive reagent for testing of blood coagulation containing ellagic acid and divalent metal ions and method of making the same
FI102273B (fi) *	1989-09-11	1998-11-13	Eisai Co Ltd	Kinonijohdannaiset, niiden valmistaminen ja niiden farmakologinen käyt tö
EP0525035B1 (de) *	1990-04-17	1996-07-03	Analytical Control Systems, Inc.	Koagulationsassays und reagenzien
US5302531A (en) *	1992-10-22	1994-04-12	Miles Inc.	Composition for the semiquantitative determination of specific gravity of a test sample

1994
- 1994-11-04 JP JP7513430A patent/JPH08510057A/ja active Pending
- 1994-11-04 EP EP95901136A patent/EP0677171B1/de not_active Expired - Lifetime
- 1994-11-04 DE DE69423738T patent/DE69423738T2/de not_active Expired - Fee Related
- 1994-11-04 WO PCT/US1994/012693 patent/WO1995012818A1/en not_active Ceased
- 1994-11-04 AU AU10494/95A patent/AU674265B2/en not_active Ceased
- 1994-11-04 CA CA002152954A patent/CA2152954A1/en not_active Abandoned
- 1994-11-04 AT AT95901136T patent/ATE191278T1/de not_active IP Right Cessation
1995
- 1995-06-07 US US08/484,373 patent/US5550028A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU1049495A (en)	1995-05-23
EP0677171B1 (de)	2000-03-29
DE69423738T2 (de)	2000-11-23
JPH08510057A (ja)	1996-10-22
US5550028A (en)	1996-08-27
CA2152954A1 (en)	1995-05-11
AU674265B2 (en)	1996-12-12
EP0677171A1 (de)	1995-10-18
WO1995012818A1 (en)	1995-05-11
DE69423738D1 (de)	2000-05-04

Similar Documents

Publication	Publication Date	Title
ES2088992T3 (es)	1996-10-01	Metodo para determinar los niveles de factores de coagulacion intrinsecos y extrinsecos y proteina c.
DE3484832D1 (de)	1991-08-29	Nachweis von bakterien mittels nukleinsaeuren-hybridisation, markierte sonden und testsatz dafuer.
DE69506434D1 (de)	1999-01-14	Blutplättchen blockade test
DE3587724D1 (de)	1994-02-24	Antikörper verwendende diagnostische Methoden.
DE69018910D1 (de)	1995-06-01	Verfahren zur Bestimmung des endogenen Thrombinpotentials von Plasma und Blut und Reagenziensatz zur Verwendung in besagtem Verfahren.
FI915150A7 (fi)	1991-10-31	Menetelmät, reagenssit ja testikäyttöpakkaukset biologisten yksiköiden alapopulaatioiden määrittämiseksi
ATE203567T1 (de)	2001-08-15	Verbesserte in vitro verfahren, testkits und reagenzien zum screening von blutgerinnungsfehlern
ATE162632T1 (de)	1998-02-15	Messung von blutplättchenaktivitäten
DK173090D0 (da)	1990-07-19	Forbedrede ekstraktionsmetoder til fremstilling af thromboplastinreagenser
ATE191278T1 (de)	2000-04-15	Tetrahydroxychinon als eine aktivatorkomponente für den aktivierten partiellen thromboplastinzeit-test der blutgerinnung und als anzeiger von blutgerinnungsstörungen
DK0690991T4 (da)	2004-02-16	Ny antikoagulant-cofaktor-aktivitet
DE58908628D1 (de)	1994-12-15	Mittel für immunchemische Tests, carboxylgruppenhaltige Polymere enthaltend.
DE69124030D1 (de)	1997-02-20	Testverfahren, die ein lösliches fibrinähnliches Monomer nutzen
DE59010919D1 (de)	2001-04-12	N- und O-substituierte Aminophenolderivate, Zwischenprodukte zu deren Herstellung, deren Verwendung als Hydrolasesubstrate, ein entsprechendes Bestimmungsverfahren und hierfür geeignetes diagnostisches Mittel
KR960008310A (ko)	1996-03-22	혈액의 응고성 측정을 위한 진단 시험용 첨가제, 진단 시험에서의 헤파린에 의한 영향을 감소시키는 방법 및 이러한 목적을 위한 금속염의 용도
DE58903500D1 (de)	1993-03-25	Fibrin(ogen) derivate, verfahren zu ihrer herstellung und ihre vewendung.
Ouyang et al.	1976	The effects of the purified thrombin-like and anticoagulant principles of Agkistrodon acutus venom on blood coagulation in vivo
DK0570356T3 (da)	1999-09-20	Reagens til bestemmelse af den aktiverede partielle thromboplastintid (APTT)
DK0570355T3 (da)	1999-08-30	Anvendelse af prothrombin-fragmenter
ES2159535T3 (es)	2001-10-16	Metodo para la determinacion de la actividad de una substancia de ensayo.
DE69025008D1 (de)	1996-03-07	Verfahren für direkte chemische Bindung des D-Dimers aus einer biologischen Probe zwecks Diagnostik und Überwachung von thrombolytischen und hyperkoagulablen Zuständen
DE69532611D1 (de)	2004-04-01	Mittel zur behandlung von autoimmunkrankheiten
JP2000329770A (ja)	2000-11-30	トロンビン／アンチトロンビン系の機能性を評価するための包括的試験
JPS642600A (en)	1989-01-06	Kit for measuring protein c activity
DE69520725D1 (de)	2001-05-23	Verfahren zur Diagnose von Blutgerinnungsstörungen

Legal Events

Date	Code	Title	Description
2000-10-15	UEP	Publication of translation of european patent specification
2002-02-15	REN	Ceased due to non-payment of the annual fee